Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-03-02 @ 6:23 PM
Study NCT ID:
NCT00486460
Status:
UNKNOWN
Last Update Posted:
2007-06-14
First Post:
2007-06-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor:
Tel-Aviv Sourasky Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
TASMC-07-NA-132-CTIL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None